Bvf Inc Eledon Pharmaceuticals, Inc. Call Options Transaction History
Bvf Inc
- $2.28 Billion
- Q1 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding ELDN
# of Institutions
87Shares Held
37.3MCall Options Held
10.5KPut Options Held
66.8K-
Ra Capital Management, L.P. Boston, MA3.57MShares$10.7 Million0.25% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.95MShares$8.86 Million0.0% of portfolio
-
First Light Asset Management, LLC Edina, MN2.33MShares$6.99 Million1.01% of portfolio
-
Sphera Funds Management Ltd. Tel Aviv, L32.31MShares$6.92 Million2.06% of portfolio
-
Blue Owl Capital Holdings LP New York, NY1.82MShares$5.46 Million3.19% of portfolio
About Eledon Pharmaceuticals, Inc.
- Ticker ELDN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 13,756,800
- Market Cap $41.3M
- Description
- Eledon Pharmaceuticals, Inc., clinical stage biopharmaceutical company, focuses on developing medicines for the patients living with autoimmune disease and amyotrophic lateral sclerosis (ALS), and requiring an organ or cell-based transplant. Its lead product candidate includes AT-1501, a humanized monoclonal antibody to target CD40 Ligand that i...